Skip to main content

Table 3 Median and range for ICIQ NQol by treatment with p-value and standardized effect size, d

From: Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS)

Measure

Treatment

A: Placebo

B: Melatonin

p

d

Median

Range

Median

Range

Overall score

25.0

8–35

20.0

8–42

0.341

0.261

Overall interference

5.0

0–9

4.0

0–9

0.444

0.209

Sleep/Energy sub-score

11.0

3–19

10.0

3–18

0.549

0.164

Bother/Concern sub-score

9.5

4–21

9.0

3–16

0.288

0.292